- €101.09m
- €149.27m
- €160.80m
- 68
- 98
- 53
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 93.5 | 75.5 | 84.8 | 235 | 161 |
Cost of Revenue | |||||
Gross Profit | 64.6 | 49.5 | 53 | 132 | 121 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 89 | 183 | 74.1 | 170 | 113 |
Operating Profit | 4.57 | -107 | 10.7 | 65.5 | 47.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.962 | -113 | 3.4 | 55.8 | 36.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.618 | -34.2 | 3.14 | 3.35 | 49.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.623 | -34.2 | 3.15 | 3.35 | 49.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.623 | -34.2 | 3.15 | 3.35 | 49.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.014 | 0.708 | -0.122 | -0.056 | 0.795 |
Dividends per Share |